- 関
- Phosphodiesterase inhibitors
WordNet
- a substance that retards or stops an activity
- the 16th letter of the Roman alphabet (同)p
PrepTutorEJDIC
- 抑制する人(物) / 化学反応抑制剤
- parking
- phosphorusの化学記号
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Targetting cancer with Ru(III/II)-phosphodiesterase inhibitor adducts: A novel approach in the treatment of cancer.
- Koiri RK, Mehrotra A, Trigun SK.SourceBiochemistry and Molecular Biology Lab, Department of Zoology, Banaras Hindu University, Varanasi, Uttar Pradesh 221005, India. Electronic address: rajkumarfrombhu@yahoo.com.
- Medical hypotheses.Med Hypotheses.2013 Jun;80(6):841-6. doi: 10.1016/j.mehy.2013.03.029. Epub 2013 Apr 12.
- Lack of specificity and normal tissue toxicity are the two major limitations faced with most of the anticancer agents in current use. Due to effective biodistribution and multimodal cellular actions, during recent past, ruthenium complexes have drawn much attention as next generation anticancer agen
- PMID 23587478
- Adjuvant host-directed therapy with type 3 and 5 phosphodiesterase inhibitors, but not type 4, shortens the duration of tuberculosis treatment.
- Maiga M, Ammerman NC, Maiga MC, Tounkara A, Siddiqui S, Polis M, Murphy R, Bishai WR.SourceCenter for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- The Journal of infectious diseases.J Infect Dis.2013 May 2. [Epub ahead of print]
- Background. Shortening tuberculosis (TB) treatment could significantly improve patient adherence and decrease the development of drug resistance. Phosphodiesterase inhibitors (PDE-Is) have been shown to be beneficial in animal models of TB. We assessed the impact of PDE-Is on the duration of treat
- PMID 23641020
- Combination of preparative HPLC and HSCCC methods to separate phosphodiesterase inhibitors from Eucommia ulmoides bark guided by ultrafiltration-based ligand screening.
- Shi SY, Peng MJ, Zhang YP, Peng S.SourceKey Laboratory of Hunan Forest Products and Chemical Industry Engineering, Jishou University, Zhangjiajie, 427000, China, shishuyun@126.com.
- Analytical and bioanalytical chemistry.Anal Bioanal Chem.2013 May;405(12):4213-23. doi: 10.1007/s00216-013-6806-4. Epub 2013 Feb 13.
- Phosphodiesterase (PDE) inhibitors are widely used because of their various pharmacological properties, and natural products are considered the most productive source of PDE inhibitors. In this work, a new ultrafiltration-high-performance liquid chromatography (HPLC)-diode-array detection-mass spect
- PMID 23404133
Japanese Journal
- Implantation of Autologous Bone Marrow-derived Cells Improves Erectile Dysfunction in Spontaneously Hypertensive Rats
- PDE5阻害薬,sGC刺激薬の心血管病変適応への展望 (第5土曜特集 循環器薬物療法UPDATE) -- (主要な薬物の特徴とエビデンス)
- Pharmacological Profile of GPD-1116, an Inhibitor of Phosphodiesterase 4
Related Links
- It may also have the potential to treat fibrotic lung disease selleck bio based on OSM biology. Conclusion Our data highlight the importance of binding affinity and off rate effect of a mAb to fully neutralize Inhibitors,Modulators,Libraries ...
- pde-inhibitors GSK256066 is an exceptionally high affinity and selective PDE4 inhibitor with an IC50 of 3.2 pM for PDE4B. Search Main menu Skip to primary content Skip to secondary content Home Sample Page September 2012 ...
★リンクテーブル★
[★]
[★]
- 関
- blocker、depressant、suppressant
[★]
[★]
ホスホジエステラーゼ phosphodiesterase